OVERVIEW

Noetic Fund

Noetic invests globally to build emerging technologies in molecular therapeutics/biotech, digital health, medical devices, and wellness with a focus on mental health, pain, and other complications resulting from the central nervous system. 

About

noetic

“From the Greek noēsis/ noētikos meaning inner wisdom, direct knowing, or subjective understanding”

Noetic science refers to a multidisciplinary field that brings objective scientific tools and techniques together with subjective understanding to study the full range of human experience.

Mission

Our mission is to nurture the scientific advancement of mental, emotional, and physiological health by investing in emerging therapies, modalities, and sciences that are committed to optimizing our human experience.

Commitment

We are committed to developing sustainable therapies, products, and services that are innovative, safe, and accessible to create a better mental health landscape for current and future generations.

Focus

CNS-targetted therapeutics and related sustainable solutions for mental health and physical well being.

Investment

Our Portfolio

Noetic Funds focus on finding teams with the skills, expertise, management experience, and governance structures in place to build world class companies.  Below is a selection of companies we have invested in.

Fund I

Woven Science

Woven Science is a holding company that creates and supports early-stage psychedelic and wellness companies in the US, Canada and Europe. As a conscious, permanent investment platform we aim to align companies based on shared values and a common vision to create a new paradigm of care that is holistic, regenerative and reciprocal.

Fund II

Meet The Team

Our Team

Sa'ad Shah

Managing Partner

9 years at RBC Capital Markets in real estate banking, corporate credit, and derivative sales & trading

9 years at DGAM (acquired by The Carlyle Group) – Head of Marketing and Client Services, helped build AUM to $6.8B at peak

BA in Economics and Political Science from Columbia University.

Warren Wright - Noetic

Warren Wright

Managing Partner

9 years at Northwater Capital Management, as Managing Director – Head of Hedge Fund Investments

12 years at DGAM (acquired by The Carlyle Group) as Chief Investment Officer

Partner at The Carlyle Group and Chief Investment Officer of The Carlyle Liquid Markets Group.

Craig Hippern

COO & CFO

25+ years in the onshore and offshore investment industry

10 years as CFO with a Bermuda-based hedge fund and a Canadian real estate development company

8.5 years at Northwater Capital Management, as VP of Finance & Risk Mgmt. and Hedge Fund Investment Due Diligence

CPA,CA (Canada) and CPA(IL) (U.S.A.)

Richard Cheung, B.Sc.Phm., Ph.D., LL.B.

General Counsel

15+ years advising clients ranging from start-ups to multinational corporations on intellectual property and regulated health products at firms including Fasken, Ogilvy Renault, and Bereskin & Parr

Licensed pharmacist in the Province of Ontario with experience in community and hospital pharmacy

LL.B. from Western University

Ph.D. in Pharmaceutical Sciences and B.Sc.Phm. (Pharmacy) from the University of Toronto

Registered Patent Agent and Trademark Agent in Canada

Preetha Nooyi

Principal, Business Development USA

8 years of experience across M&A, innovation, consumer insights, and product development roles in the consumer-packaged goods sector

Co-developed the investment thesis and strategic framework to screen potential CPG acquisitions and investments at Lindsay Goldberg

5 years of training and class facilitation in leadership development at Yale School of Management

MBA from Yale School of Management

BA from Hamilton College

Sri Teja Mullapudi, PhD

Principal, Fund Investments, Scientific Lead

Helped raise and deploy $60M+ in the psychedelic and neuroscience sectors to improve mental healthcare

Experienced in life sciences investment opportunity analyses from TIAP (MaRS Innovation)

8+ years of research experience with 8 publications in peer-reviewed journals

Ph.D. (summa cum laude) in Biology from the Max Planck Society, Germany

M.Tech + B.Tech in Biotechnology (Minor in Chemistry) from Indian Institute of Technology Madras, India

Soccer player with TSV Rödgen, Germany (2014-18), Toronto City FC, Canada (2019-21)

David Schnarr

CCO & Head of Operations

20+ years at Maple Financial Group Inc.,  serving in a variety of senior finance,  compliance and administrative functions

2 years as CFO and CCO at Clearpool Execution Services Canada.  Started IIROC-regulated broker-dealer from the beginning.  (Company was purchased by BMO in 2020)

Professional designations:  CPA, CMA (Canada) and CFA 

Daria Zhukova

Senior Associate, Administration & Accounting

3+ years of experience in business operations and office administration.  

Managed financial accounting for multimillion-dollar corporations, including companies operating in the medical and pharmaceutical industries. 

BA in Economics and Mathematics from the University of British Columbia, with one year of study at the National University of Singapore, focusing on financial markets and macroeconomics 

Andy Bottomley

Senior Venture Partner

Andy is a 25+ year experienced venture capital and growth investor, CEO and company director with significant international experience.

He has wide experience and interests as an operator/investor and board level advisor at every stage of company lifecycle across the capital structure. He has experience with all transaction types public and private.

Andy is based in London,  working closely with the Noetic senior team on strategic issues, most notably fund raising and strategic growth.

Matthew Baggott, PhD​​

Venture Partner

CEO of Tactogen

30-year career spanning data science, preclinical pharmacology, clinical research, neuroscience, genomics and drug development

Bachelor’s degree in Philosophy and Post-doctoral Fellow at the University of Chicago

Ph.D. in Neuroscience from the University of California, Berkeley.

Jeffrey Becker, MD

Venture Partner

CSO & Co-Founder of Bexson Biomedical, Inc.

Board-certified in Psychiatry and Integrative & Holistic Medicine

Leader in applied genetics and functional nutrient science in mental health

Ketamine assisted psychotherapy trainer and opinion leader

UC Berkeley Bachelor’s in Biology, Entomology & Religious Mysticism; UCLA Medical graduate & psychiatric resident

David Rabin, MD, PhD​​

Venture Partner

CIO of Apollo Neuroscience

Board-certified psychiatrist, neuroscientist, tech entrepreneur & inventor

Operates a clinical psychiatry practice and conducting research on the epigenetic regulation of trauma responses and recovery

Graduate degrees from Albany Medical College and psychiatric residency from Pittsburgh Medical Center.

Prof. Ede Frecska, PhD

Advisor

Chairman of Psychiatry at the Faculty of Medicine of the University of Debrecen

Residency training in Psychiatry both in Hungary (1986), and in the United States (1992)

Qualified psychopharmacologist (1987) of international merit

17 years of clinical and research experience in the United States.

Marci Freedman

Advisor

25+ years of lifestyle marketing experience with companies including Reebok and Vitaminwater.

8 years developing, executing and implementing national programs which helped define and build the Vitaminwater and Smartwater brands.

Advisory Board member of Cloud Water Brands, Gem&Bolt Mezcal and Prosper Technologies Holdings to name a few.

Adventurer, Explorer, and World Traveler.

Vanessa Levi

Advisor

9 years at Russell Investments – Head of Italy, helped build AUM to $8B and opened Milan office

6 years as Managing Partner of a single family office investing across all asset classes

6 years in healthcare research and consultancy at Datamonitor and Frost & Sullivan 

BA Hon in Business Administration from European Business School in London

Jody Levy

Advisor

Jody Levy is an artist, designer, director, entrepreneur, executive and investor.

Jody is the founder, creative director and Chief Executive Officer of a handful of companies dedicated to empowering people to be as healthy and happy as possible.

Luis Eduardo Luna, PhD

Advisor

Guggenheim Fellow (1986), Fellow of the Linnaean Society of London (1989), and Doctor Honoris Causa, from St. Lawrence, Canton, New York (2002)

Ph.D. from the Department of Comparative Religion Stockholm University (1989)

Master from Oslo University (1980)

B.A. from Madrid University (1972).

Victor Mifsud

Advisor

10+ years in the psychedelic/health optimization space. Founder of the Vision Optimization Summit.
 
Recently completed a feature-length documentary film called “My Neuroplastic Adventure“.
 
Worked/mentored with renowned national best-selling author and physician Dr. Gabor Maté, Dr. Lara Boyd, and Dr. Norman Doidge to name a few.
 
Ryerson University – New Media & Film 

Press

BLOG PoSTS

Sa’ad’s Reading List

Noetic Fund’s Sa’ad Shah is often asked for his favourite books on entheogens and the complex workings of our psyche. We would like to share

Read More »

Subscribe

Subscribe to keep in touch and learn about the latest developments in the emerging psychedelic medicine space

CONTACT US

Who to Contact

Do you have a question about our Fund?

Please feel free to get in touch by sending us an email to info@noeticfund.com.

Do you have a question about your investment?

Please feel free to get in touch by sending us an email to ir@noeticfund.com.

Do you want the Fund to invest in your company?

Please feel free to get in touch by sending us an email to info@noeticfund.com.

@NoeticFund

Join us on Instagram